On this page
At a glance / Promise
Our take
Promise provides unusually explicit first-versus-renewal pricing for the reviewed single product. That makes it possible to ask concrete commercial questions, without treating the service as evidence of BPC-157 effectiveness. Compare published provider terms, record a complete written quote and retain unanswered questions for a clinician. This is a documentary review, not firsthand care experience or a clinical score.
- Published offer
- Single BPC-157 injectable listing; precise injection route unresolved
- Advertised starting price
- Single BPC-157: $229 first; $279 per 28-day renewal
- Billing basis
- Recurring subscription every 28 days; higher renewal price
- Refund boundary
- Cancellation stops future renewals; processed charges not automatically reversed, shipped medication may be nonrefundable
- State and pharmacy match
- Exact product-state eligibility and dispensing pharmacy/license not independently verified
Useful details
- Explicit first and renewal pricing with 28-day interval
- Care, medication, cold shipping and check-ins described in package
What to weigh
- The repeating amount is higher than the introductory price
- Precise route and product-specific pharmacy/state match remain unresolved
A review of published information, not a treatment experience or a clinical quality rating. Source check: 2026-10-29.
The product under review
The official BPC-157 listing is distinct from Promise’s Wolverine and KLOW combinations. Its published package describes an injectable product, but the retrieved detail did not establish the specific injection route. This report keeps that limitation visible. Matching a product to human evidence or an ingredient-specific policy requires more than recognizing BPC-157 in the title.
The recurring price record
The first amount is $229. Subsequent charges are described as $279 every 28 days. The difference is material both because the amount rises and because the interval is shorter than a calendar month. A cost comparison should model actual dates and charges. It should not annualize the introductory amount or call a repeating four-week payment one monthly charge.
What the bundle represents
The page describes review, prescription, medication, cold shipping and check-ins as included. According to the terms, visit submission creates a temporary authorization and clinician approval precedes the first capture. That is a published payment sequence, not a guarantee of a particular prescription. Ask what documentation identifies the clinician, actual dispensing pharmacy and agreed service after approval.
The cancellation record
The terms describe cancellation through online instructions, support email or phone. Receipt stops future renewals, without automatically reversing a charge already processed. Shipped medication may be nonrefundable, subject to applicable law or an approved request. Keep cancellation and refund questions separate when recording the commitment; one answers the next renewal, the other concerns money already charged.
What remains outside the record
Broad state coverage language is qualified by treatment-specific availability. We have not independently established the exact BPC product-state matrix, pharmacy assignment or license, and have not completed an intake. The current availability briefing explains why a draft policy, an official product listing and an individual prescription pathway should remain separate pieces of evidence.
The report conclusion
Promise provides unusually explicit first-versus-renewal pricing for the reviewed single product. That makes it possible to ask concrete commercial questions, without treating the service as evidence of BPC-157 effectiveness. Compare published provider terms, record a complete written quote and retain unanswered questions for a clinician. This is a documentary review, not firsthand care experience or a clinical score.
Sources & further reading
Primary research, provider documents and policy sources used in this article. Sources do not endorse this publication.
Source review: 2026-10-29. Provider terms and policy documents can change.